Caricamento...
Adoption of Abiraterone and Enzalutamide by Urologists
OBJECTIVE: To investigate the adoption of abiraterone and enzalutamide by urologists. Abiraterone and enzalutamide are oral therapies approved for the treatment of metastatic castration-resistant prostate cancer, a disease most commonly treated by medical oncologists. METHODS: Using the Medicare Par...
Salvato in:
| Pubblicato in: | Urology |
|---|---|
| Autori principali: | , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6711811/ https://ncbi.nlm.nih.gov/pubmed/31136769 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.urology.2019.05.012 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|